Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Injury ; 51(12): 2779-2785, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32958346

ABSTRACT

Management of posterior tibial plateau fractures has gained much interest over the past few years. Fracture morphology, trauma mechanism, and soft-tissue injury have been identified as the key factors determining the treatment strategy and outcome. We provide a rationale for the operative management of posterior tibial plateau fractures by discussing the interplay between fracture morphology, trauma mechanism, and soft-tissue injury. The trauma mechanism has proven to be an important tool, not only to understand fracture morphology, but also to assess concomitant soft-tissue (i.e. ligamentous) injury. Subsequently, soft-tissue injury might play a role in future classification and diagnostic work-up of tibial plateau fractures, particularly in fractures with posterior involvement. Plate osteosynthesis using a posterior approach is safe and should be considered routinely in coronal fractures of the posterior tibial plateau, as illustrated.


Subject(s)
Soft Tissue Injuries , Tibial Fractures , Bone Plates , Fracture Fixation, Internal , Humans , Retrospective Studies , Soft Tissue Injuries/surgery , Tibial Fractures/diagnostic imaging , Tibial Fractures/surgery
3.
Anal Chem ; 70(9): 1823-30, 1998 May 01.
Article in English | MEDLINE | ID: mdl-21651276

ABSTRACT

Different mass spectrometric approaches were used to identify an original non-terpenoid varnish. Direct temperature-resolved MS and pyrolysis-GC/MS mainly showed the phenolic components, whereas thermally assisted (trans)methylation with tetramethylammonium hydroxide (TMAH) strongly enhanced the evidence for tung oil as part of the varnish. Transethylation studies of the fatty acids confirmed the TMAH data. The degree of hydrolysis of the oil network was found to be low. No evidence was found for a direct link between the drying oil and phenolic resin. On the basis of the MS information, the aged varnish is identified as an open-structure tert-butylphenol-formaldehyde resin which entangles the tung oil polymer.

4.
Int J Cancer ; 71(6): 959-65, 1997 Jun 11.
Article in English | MEDLINE | ID: mdl-9185697

ABSTRACT

Bcl-2 over-expression has been shown to inhibit apoptosis induced by a variety of stimuli, whereas a predominance of Bax alpha to Bcl-2 accelerates apoptosis upon apoptotic stimuli. We sought to study the relevance of these apoptotic regulating gene products in leukaemia. In a panel of leukaemia and lymphoma cell lines (HL60, DoHH2, CEM C7, L1210 and S49), the Bax alpha-to-Bcl-2 ratio as assessed by Western-blot analysis correlated with sensitivity to dexamethasone treatment. In addition, in HAbax alpha-transfected CEM C7 clones, a similar correlation was found for dexamethasone and thapsigargin sensitivity. In bone-marrow aspirates from patients with childhood acute lymphoblastic or myelocytic leukaemia (ALL, n = 48; AML, n = 8), the Bcl-2 and Bax alpha levels were highly variable, but well within the range found in the Bax alpha transfectants and in the established cell lines. Bcl-2 levels were lower in T- than in B-lineage ALL, which could be ascribed to simultaneous inverse relation between Bcl-2 and WBC. By contrast, Bax alpha:Bcl-2 was independent of any presenting feature and was largely dependent on Bax alpha levels. Results suggest that Bax alpha:Bcl-2, rather than Bcl-2 alone is important for the survival of drug-induced apoptosis in leukemic cell lines and ALL.


Subject(s)
Dexamethasone/pharmacology , Leukemia, Myeloid, Acute/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins/genetics , Apoptosis/drug effects , Child , Humans , Leukemia, Myeloid, Acute/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Thioguanine/pharmacology , Tumor Cells, Cultured , bcl-2-Associated X Protein
5.
Cancer Chemother Pharmacol ; 40(2): 131-7, 1997.
Article in English | MEDLINE | ID: mdl-9182834

ABSTRACT

meta-Iodobenzyl guanidine (MIBG) combines the structural properties of the neuron-blocking agents bretylium and guanethidine and is being used increasingly for various clinical applications. Different samples of MIBG were assayed for possible contamination with benzyl guanidine (BG). Fast-atom-bombardment mass spectrometry (FAB-MS) analysis showed a prominent but variable m/z 150 signal, corresponding to a protonated BG. The MS/MS fragmentation pattern of these [M + H]+ ions was similar to that obtained from FAB-MS-generated, protonated BG, confirming the proposed molecule and associated structures. RP-HPLC analysis of both guanidines, however, excluded the possibility of contamination of MIBG with BG. It was therefore concluded that the BG signal was an artifact of the FAB-MS procedure. In addition, the importance of the meta-substituted iodine for the biological activity of MIBG was investigated. Three different biochemical and cell-biological properties of MIBG were compared with those of its precursor MIBA and BG. The assays used were: inhibition of the catecholamine "Uptake I" system in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells, inhibition of mitochondrial respiration, and general cytotoxicity in L1210 leukemia cells. Of the drugs tested, MIBG was the most efficient in Uptake I inhibition and was more toxic in survival assays, but as compared with BG it was almost equipotent in inhibiting mitochondrial respiration. These findings contribute to a further elucidation of the mechanism by which MIBG exerts its various actions.


Subject(s)
Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Guanidines/chemistry , Guanidines/pharmacology , Iodine Radioisotopes/chemistry , Iodine Radioisotopes/pharmacology , Iodobenzenes/chemistry , Iodobenzenes/pharmacology , 3-Iodobenzylguanidine , Animals , Catecholamines/metabolism , Cell Respiration/drug effects , Chromatography, High Pressure Liquid , Leukemia L1210/pathology , Mitochondria/drug effects , Spectrometry, Mass, Fast Atom Bombardment
6.
J Steroid Biochem Mol Biol ; 57(3-4): 239-49, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8645634

ABSTRACT

Nuclear translocation of activated glucocorticoid receptors (GRs) is a necessary step in the signal transduction by these GC hormones. Although in vitro activation of GRs can occur in the absence of a functional ligand, it is generally assumed that binding of a cognate hormone is required for activation of the intracellular GR. By indirect immunocytochemistry and Western-blot analysis, it was found that, in spontaneously aggregated human lymphoma DoHH2 cells, hormone-free GRs are located in the nucleus. Disruption of the aggregates redistributed GRs to a predominantly cytosolic location. Upon spontaneous re-aggregation the GR again became localized to the nucleus. Intracellular cross-linking of the heteromeric receptor complex was applied to investigate the protein composition of cytoplasmic and nuclear receptors. Untransformed, cytosolic GRs could be demonstrated by [3H]dexamethasone binding capacity and hsp90 co-immunoprecipitation, whereas absence of these characteristics suggested an activated conformation of the nuclear GRs. These observations suggest that cell-cell interactions are capable of transforming GRs in the absence of a ligand.


Subject(s)
Cell Nucleus/metabolism , Lymphoma, B-Cell/metabolism , Receptor Aggregation/physiology , Receptors, Glucocorticoid/metabolism , Signal Transduction/physiology , Adenosine Diphosphate/analysis , Adenosine Triphosphate/analysis , Binding Sites , Cell Cycle , Cell Nucleus/chemistry , Cross-Linking Reagents , Cytosol/chemistry , Cytosol/metabolism , Dexamethasone/metabolism , Glucocorticoids/metabolism , HSP90 Heat-Shock Proteins/metabolism , Humans , Ligands , Receptors, Glucocorticoid/analysis , Succinimides , Tumor Cells, Cultured
7.
Leuk Lymphoma ; 20(3-4): 199-205, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8624457

ABSTRACT

The lytic response of lymphoid cells to glucocorticoid hormones (GC) is prototypical of the induction of apoptosis: a special form of cellular demise for the removal of unwanted or redundant cells. Initiation and execution of a death programme are therefore major checkpoints in GC-sensitivity. Although Bcl-2 protein can prevent or delay apoptosis of lymphoma and leukemia cells, exposed to multiple cytotoxic agents, its antagonism of GC-induced apoptosis appears most critical in conferring resistance to corticosteroids. Moreover, Bcl-2 may modulate GC-signalling to apoptosis through its association with fundamental cellular processes such as energy state, Ca2+ homeostasis and transmembrane transport. However, this signalling pathway can also be interrupted by Bcl-2- independent mechanisms. This review discusses the various cellular and oncogenetic factors that control GC sensitivity of leukemia/lymphoma cells and proposes a hypothesis of how GC may induce a death programme, sensitive to blockade by Bcl-2.


Subject(s)
Apoptosis/drug effects , Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Leukemia/pathology , Lymphocytes/cytology , Lymphoma/pathology , Adenosine Triphosphate/metabolism , Animals , CD3 Complex/physiology , Cell Division/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Humans , Leukemia/metabolism , Lymphoma/metabolism , Mice , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-bcl-2 , Rats , Tumor Cells, Cultured
8.
Mol Microbiol ; 15(4): 627-38, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7783635

ABSTRACT

Rhizobium loti is a fast-growing Rhizobium species that has been described as a microsymbiont of plants of the genus Lotus. Nodulation studies show that Lotus plants are nodulated by R. loti, but not by most other Rhizobium strains, indicating that R. loti produces specific lipo-chitin oligosaccharides (LCOs) which are necessary for the nodulation of Lotus plants. The LCOs produced by five different Rhizobium loti strains have been purified and were shown to be N-acetylglucosamine pentasaccharides of which the non-reducing residue is N-methylated and N-acylated with cis-vaccenic acid (C18:1) or stearic acid (C18:O) and carries a carbamoyl group. In one R. loti strain, NZP2037, an additional carbamoyl group is present on the non-reducing terminal residue. The major class of LCO molecules is substituted on the reducing terminal residue with 4-O-acetylfucose. Addition of LCOs to the roots of Lotus plants results in abundant distortion, swelling and branching of the root hairs, whereas spot inoculation leads to the formation of nodule primordia.


Subject(s)
Chitin/analogs & derivatives , Fabaceae/microbiology , Plants, Medicinal , Rhizobium/metabolism , Symbiosis/physiology , Bacterial Proteins/metabolism , Carbohydrate Sequence , Chitin/chemistry , Chitin/physiology , Chromatography, High Pressure Liquid , Chromatography, Thin Layer , Magnetic Resonance Spectroscopy , Molecular Sequence Data , Spectrometry, Mass, Fast Atom Bombardment
9.
J Steroid Biochem Mol Biol ; 51(1-2): 33-40, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7947348

ABSTRACT

Upon agonist binding the heteromeric glucocorticoid receptor complex undergoes a conformational change (receptor activation). This event involves the dissociation of a dimer of 90 kDa heat shock proteins. Whereas receptor activation in cytosolic assays is both rapid and irreversible, less is known about the receptor activation and translocation in intact cells during challenge with an agonist. In this paper we report on the receptor status of glucocorticoid-sensitive murine S49 lymphoma cells during dexamethasone exposure. By three different assays, ligand (re)binding, nuclear translocation and hsp90 co-immunoprecipitation, it was found that the majority of the glucocorticoid receptor protein was in a non-activated conformation. Furthermore, prolonged exposure to dexamethasone did not result in increased levels of activated receptors. By assessing receptor activation in situ we found that physiological temperature was less effective in dissociating hsp90 compared to room temperature. These findings indicate that the physiological temperature negatively controls receptor activation, probably due to a thermolabile interaction between the hormone and its cognate receptor.


Subject(s)
Dexamethasone/pharmacology , Lymphoma/metabolism , Receptors, Glucocorticoid/metabolism , Signal Transduction/physiology , Animals , Apoptosis/drug effects , Cell Nucleus/metabolism , Cytosol/chemistry , HSP90 Heat-Shock Proteins/metabolism , Ligands , Mice , Receptors, Glucocorticoid/chemistry , Temperature , Tumor Cells, Cultured
10.
Leuk Res ; 17(3): 263-9, 1993 Mar.
Article in English | MEDLINE | ID: mdl-8450675

ABSTRACT

The validity of in vitro assays in predicting the susceptibility of leukaemic cells to glucocorticoid-mediated lysis was evaluated in a panel of six murine leukaemia cell lines. In this panel susceptibility to glucocorticoids ranged from highly sensitive to fully resistant. The panel was screened for specific 3H-dexamethasone binding in whole cells and for activation of cytosolic receptors in cell lysates. Specific binding of 3H-dexamethasone was strongly affected by the incubation temperature. In all cell lines, rapid and reversible changes were observed in the stability of agonist-receptor association with a transition temperature of 28 degrees C. Below this temperature, intracellular receptors were found to be in a stable-binding, high-affinity configuration, masking differences in receptor status among the various cell lines. When assayed at 37 degrees C, refractory and fully resistant cells revealed nonsaturating, low-affinity binding of steroid. Saturating, high-affinity binding was, however, restored in these cells by the drug meta-iodobenzylguanidine with concomitant sensitization to dexamethasone-induced lysis. Contrary to observations with intact cells, heat-induced agonist-receptor dissociation in cytosols caused irreversible loss of (re)binding capacity. Activation of cytosolic receptors only recognized fully resistant cell lines as being deficient in the transformation of liganded receptors into a DNA-binding configuration. The assay, however, could not discriminate between three cell lines with highest but varying degrees of sensitivity because of maximal activation. The results indicate that non-physiological temperature and cell disruption strongly and differentially affect steroid binding and receptor activation, respectively. The observations may account for the poor correlation between conventional predictive assays and steroid responsiveness in clinical leukaemia.


Subject(s)
Glucocorticoids/metabolism , Leukemia L1210/metabolism , Receptors, Glucocorticoid/metabolism , 3-Iodobenzylguanidine , Animals , Antineoplastic Agents/pharmacology , Cytosol/metabolism , DNA, Neoplasm/metabolism , Dexamethasone/metabolism , Drug Resistance , Drug Screening Assays, Antitumor , Drug Stability , Glucocorticoids/pharmacology , Iodobenzenes/pharmacology , Mice , Phenotype , Receptors, Glucocorticoid/physiology , Temperature , Tritium , Tumor Cells, Cultured
11.
Eur J Biochem ; 205(2): 737-42, 1992 Apr 15.
Article in English | MEDLINE | ID: mdl-1315274

ABSTRACT

Human neutrophilic myeloperoxidase (MPO) is involved in the defence mechanism of the body against micro-organisms. The enzyme catalyses the generation of the strong oxidant hypochlorous acid (HOCl) from hydrogen peroxide and chloride ions. In normal neutrophils MPO is present in the dimeric form (140 kDa). The disulphide-linked protomers each consist of a heavy subunit and a light one. Reductive alkylation converts the dimeric enzyme into two promoters, 'hemi-myeloperoxidase'. We studied the initial activities of human dimeric MPO and hemi-MPO at the physiological pH of 7.2 and found no significant differences in chlorinating activity. These results indicate that, at least at neutral pH, the protomers of MPO function independently. The absorption spectra of MPO compounds II and III, both inactive forms concerning HOCl generation, and the rate constants of their formation were the same for dimeric MPO and hemi-MPO, but hemi-MPO required a slightly larger excess of H2O2 for complete conversion. Hemi-MPO was less stable at a high temperature (80 degrees C) as compared to the dimeric enzyme. Furthermore, the resistance of the chlorinating activity of hemi-MPO against its oxidative product hypochlorous acid was somewhat lower (IC50 = 32 microM HOCl) compared to dimeric MPO (IC50 = 50 microM HOCl). The higher stability of dimeric MPO in the presence of its oxidative product compared to that of monomeric MPO might be the reason for the occurrence of MPO as a dimer.


Subject(s)
Chlorides/metabolism , Hypochlorous Acid/metabolism , Leukocytes/enzymology , Peroxidase/blood , Enzyme Stability , Hot Temperature , Humans , Hydrogen Peroxide/metabolism , Hydrogen-Ion Concentration , Kinetics , Macromolecular Substances , Peroxidase/isolation & purification , Spectrophotometry , Thermodynamics
SELECTION OF CITATIONS
SEARCH DETAIL
...